Zobrazeno 1 - 10
of 11
pro vyhledávání: '"D M Obzansky"'
Publikováno v:
The Journal of Automatic Chemistry
A fully automated, random access method for the determination of cannabinoids (UTHC) was developed for the Dimension AR and XL clinical chemistry systems. The method utilizes Abuscreen ONLINE reagents and a multianalyte liquid calibrator containing 1
Autor:
R. W Stout, D. M. Obzansky, D. M. Simons, S. Y. Tseng, S. Harbron, B. R. Rabin, H. EggeLte, M. J. Di Paolo, M Fisher, D. M. Severino
Publikováno v:
Clinical Chemistry. 37:1513-1518
A highly sensitive flavin adenine dinucleotide-3'-phosphate (FADP)-based enzyme amplification cascade has been developed for determining alkaline phosphatase (ALP; EC 3.1.3.1). The cascade detects ALP via the dephosphorylation of the novel substrate
Autor:
T Q, Wei, V P, Chu, A R, Craig, J E, Duffy, D M, Obzansky, D, Kilgore, I S, Masulli, C M, Sanders, J C, Thompson
Publikováno v:
Clinical chemistry. 45(3)
Monitoring of the concentration of gentamicin in serum and plasma during therapy is widely recommended and practiced in hospitals. Our aim was to develop a homogeneous immunoassay based on particle-enhanced turbidimetric inhibition immunoassay techno
Autor:
D M, Obzansky, B R, Rabin, D M, Simons, S Y, Tseng, D M, Severino, H, Eggelte, M, Fisher, S, Harbron, R W, Stout, M J, Di Paolo
Publikováno v:
Clinical chemistry. 37(9)
A highly sensitive flavin adenine dinucleotide-3'-phosphate (FADP)-based enzyme amplification cascade has been developed for determining alkaline phosphatase (ALP; EC 3.1.3.1). The cascade detects ALP via the dephosphorylation of the novel substrate
Publikováno v:
Annales de biologie clinique. 48(8)
The use of chromium dioxide particles as a solid support for very sensitive and rapid immunoassays, is the result of the combination of large surface area (40 m2) and high protein uptake capacity (40 mg/g) allowing rapid capture kinetics and high bin
Autor:
S. M. Hernandez, B Woods-Galvin, S. P. Kramer, M M Mendola, I. S. Masulli, D. M. Obzansky, A Chatterjee, C Wang, R K Wiedenmann, J P Swyka, R C Wright, Leslie M. Shaw, L B Fields
Publikováno v:
Therapeutic Drug Monitoring. 21:444
Autor:
P. D. Nagle, A. R. Craig, I. S. Masulli, D. R. Hudson, C. M. Sanders, R. C. Elser, D. S. Cooley, V. P. Chu, S. M. Hernandez, D. M. Obzansky
Publikováno v:
Therapeutic Drug Monitoring. 19:572
Autor:
D M Obzansky, K E Richardson
Publikováno v:
Clinical Chemistry. 29:1815-1819
We describe an automated (ABA-100) enzymic method for determination of urinary oxalate by use of oxalate oxidase (EC 1.2.3.4) isolated from beet stems. The H2O2 produced by the oxidation of oxalate by oxalate oxidase is measured by coupling with oxid
Publikováno v:
Clinical Chemistry. 33:1630-1634
We describe a fully automated assay for determining effective heparin activity in plasma, based on heparin-catalyzed inhibition of Factor Xa (EC 3.4.21.6) by antithrombin III (AT III). Residual Factor Xa is determined kinetically by the Du Pont aca d
Publikováno v:
Clinical chemistry. 33(9)
We describe a fully automated assay for determining effective heparin activity in plasma, based on heparin-catalyzed inhibition of Factor Xa (EC 3.4.21.6) by antithrombin III (AT III). Residual Factor Xa is determined kinetically by the Du Pont aca d